CVS Health's turnaround efforts in focus amid record-high medical costs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
CVS Health (CVS) PT Raised to $76 at Truist Securities
February 13, 2025 6:04 AM ESTTruist Securities analyst David MacDonald raised the price target on CVS Health (NYSE: CVS) to $76.00 (from $60.00) while maintaining a Buy rating.
The analyst comments "We remain bullish on CVS post 4Q marked by top and bottom-line beats while 25 guidance provides an attractive baseline.... More
